文献速递白血病

非强化治疗老年急性髓系白血病患者基因组景观与白血病发生轨迹的临床影响

Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients.
PubMed 文献 · Leukemia · 2023-08-17

该研究对一项前瞻性III期临床试验中604例接受非强化治疗的老年初诊急性髓系白血病患者进行263个基因的靶向DNA测序,利用肿瘤遗传学树模型和层次聚类描绘白血病发生轨迹,并通过多变量Cox回归建立预后分组。克隆性造血相关基因突变最常见,多变量分析识别出FLT3内部串联重复、SRSF2和TP53突变为不良预后因素,而DDX41突变预后极佳,据此划分出三个遗传学风险组。

要点

  • 克隆性造血相关基因ASXL1、TET2、SRSF2、DNMT3A突变频率最高。
  • 多变量分析显示FLT3-ITD、SRSF2和TP53突变为不良预后因素,DDX41突变预后极佳。
  • 基于DDX41、FLT3-ITD和TP53状态划分三个遗传学风险组:有利、中间和高危。

核心结论

  • 本研究识别了老年急性髓系白血病患者不同的白血病发生轨迹,并为接受较低强度治疗的患者提供了有临床意义的遗传学结局分层基础。

研究设计与样本

  • 对一项前瞻性III期临床试验中604例接受非强化治疗的老年初诊急性髓系白血病患者进行包含263个基因的靶向DNA测序。
  • 使用肿瘤遗传学树模型和层次聚类描绘白血病发生轨迹,并通过多变量Cox回归模型推导预后分组。

主要发现

  • 克隆性造血相关基因ASXL1、TET2、SRSF2、DNMT3A突变频率最高。
  • 肿瘤遗传学建模算法生成一棵具有五个分支的树,ASXL1、DDX41、DNMT3A、TET2和TP53从根部发出,提示白血病起始事件并产生具有不同亚克隆的进一步亚分支。
  • 无监督聚类反映了树模型识别的遗传学分组。
  • 多变量分析识别FLT3内部串联重复、SRSF2和TP53突变为不良预后因素,而DDX41突变表现出极好的有利效应。
  • 基于赤池信息准则的后向消除法 delineated 三个遗传学风险组:DDX41突变(有利风险)、DDX41野生型/FLT3-ITD阴性/TP53野生型(中间风险)以及FLT3-ITD或TP53突变(高风险)。

关键数值与推荐

  • 遗传学风险分组:DDX41突变为有利风险组;DDX41野生型/FLT3-ITD阴性/TP53野生型为中间风险组;FLT3-ITD或TP53突变为高风险组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To characterize the genomic landscape and leukemogenic pathways of older, newly diagnosed, non-intensively treated patients with AML and to study the clinical implications, comprehensive genetics analyses were performed including targeted DNA sequencing of 263 genes in 604 patients treated in a prospective Phase III clinical trial. Leukemic trajectories were delineated using oncogenetic tree modeling and hierarchical clustering, and prognostic groups were derived from multivariable Cox regression models. Clonal hematopoiesis-related genes (ASXL1, TET2, SRSF2, DNMT3A) were most frequently mutated. The oncogenetic modeling algorithm produced a tree with five branches with ASXL1, DDX41, DNMT3A, TET2, and TP53 emanating from the root suggesting leukemia-initiating events which gave rise to further subbranches with distinct subclones. Unsupervised clustering mirrored the genetic groups identified by the tree model. Multivariable analysis identified FLT3 internal tandem duplications (ITD), SRSF2, and TP53 mutations as poor prognostic factors, while DDX41 mutations exerted an exceptionally favorable effect. Subsequent backwards elimination based on the Akaike information criterion delineated three genetic risk groups: DDX41 mutations (favorable-risk), DDX41wildtype/FLT3-ITDneg/TP53wildtype (intermediate-risk), and FLT3-ITD or TP53 mutations (high-risk). Our data identified distinct trajectories of leukemia development in older AML patients and provide a basis for a clinically meaningful genetic outcome stratification for patients receiving less intensive therapies.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Jahn E, Saadati M, Fenaux P, et al. Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients. Leukemia. 2023. PMID: 37591941. doi:10.1038/s41375-023-01999-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。